The Silicon Valley startup has launched with a proprietary automation platform, and counts CRISPR researcher Jennifer Doudna among its new investors.
The company emerged from stealth mode this month and traces roots to both rocket maker SpaceX and the shuttered sequencing company Halcyon Molecular.
The acquisition of San Diego-based ValueGene expands IDT's presence in Southern California.
IDT said that the acquisition is expected to expand the customer base for its custom synthetic nucleic acid business across Southeast Asia.
A paper in Nature Biotechnology showed that the guide RNAs increased genome editing efficiency in human primary T cells and hematopoietic stem cells.
The company believes it can make oligonucleotide synthesis faster and cheaper than currently available methods, and plans to launch a platform in the next year.
The firm will be a preferred supplier of synthetic oligonucleotides to Research Councils UK Shared Services Centre Ltd.
The German firm will provide synthetic oligos to the RCUK Shared Services Centre Ltd.
Under the contract, Integrated DNA Technologies will supply the Research Councils UK with synthetic oligonucleotides.
Glycon will distribute and provide services for Integrated DNA Technologies' synthetic nucleic acids and related offerings.
In Science this week: metagenomic-based technique for determining protein structure, and more.
An academic laments the rise of narcissism in the sciences, the Guardian reports.
Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.
The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.